2m 2m 2m 2m 2m 2m 2m
BIONXS GENE LAB (BGLC)
NASDAQ
$2.25-$0.03 (-1.32%)
Price as of Jun 03, 2026 7:24 PM EDT- $5.6MMarket Cap
- -30.49%1-Year Change
- Specialty ChemicalsIndustry
BIONXS GENE LAB (BGLC)
$2.25-$0.03 (-1.32%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 7.4M -21.93% | 9.5M -2.66% | 9.8M -10.60% | 10.9M -18.21% | |
Cost of Revenue | 6.3M -22.89% | 8.2M -2.61% | 8.4M -12.70% | 9.7M -13.42% | |
Gross Profit | 1.1M -15.84% | 1.3M -3.01% | 1.3M +5.60% | 1.3M -42.61% | |
Sales and Marketing Expense | 1.7M -14.50% | 2.0M N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -50,670 +6.65% | -47,511 N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 111,873 +7.40% | 104,160 +25.11% | 83,253 -8.94% | 91,427 +0.16% | |
Total Operating Expenses | 4.5M +190.82% | -4.9M -211.94% | 4.4M +154.94% | 1.7M +43.59% | |
Operating Profit | -3.0M +88.41% | -1.6M -39.32% | -2.6M +790.73% | -291,177 -127.58% | |
Interest Income | 83,888 -43.18% | 147,641 N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | -13,929 N/A | N/A N/A | |
Interest Income and Expense and Net | 83,888 -43.18% | 147,641 +1,159.95% | -13,929 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 432,117 -79.15% | 2.1M +326.40% | 486,036 +171.10% | 179,283 +169.63% | |
Income before Taxes | -3.0M +87.14% | -1.6M -38.84% | -2.6M +758.71% | -303,656 -129.12% | |
Income Taxes | 0 +100.00% | -3,494 -83.77% | -21,526 -58.85% | -52,310 +95.65% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -3.0M +86.73% | -1.6M -39.20% | -2.6M +638.57% | -355,966 -147.36% | |
Net Income from Continuing Operations Applicable to Common | -3.0M +87.14% | -1.6M -38.84% | -2.6M +758.71% | -303,656 -140.40% | |
Basic EPS and Net Income | -1.61 N/A | N/A N/A | N/A N/A | N/A N/A | |
Diluted EPS and Net Income | -1.61 +1,685.56% | -0.09 N/A | N/A N/A | N/A N/A | |
Basic Weighted Average Shares | N/A N/A | 17.8M +12.24% | 15.9M -90.82% | 172.9M +0.99% | |
Diluted Weighted Average Shares | N/A N/A | 17.8M N/A | N/A N/A | N/A N/A | |
Balance Sheet | |||||
Cash and Cash Equivalents | 2.4M +50.51% | 1.6M -39.65% | 2.6M +328.86% | 611,849 +5.76% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 2.4M +50.51% | 1.6M -39.65% | 2.6M +328.86% | 611,849 +5.76% | |
Total Current Assets | 5.4M -26.67% | 7.4M -7.66% | 8.0M +33.63% | 6.0M -15.78% | |
Accumulated Depreciation | 868,849 +14.78% | 756,976 +14.85% | 659,115 +6.84% | 616,913 +17.37% | |
Property and Plant and Equipment and Net | 1.6M +4.98% | 1.5M +0.75% | 1.5M -0.006% | 1.5M -7.51% | |
Total Long-Term Assets | 3.8M +26.66% | 3.0M -10.43% | 3.4M +23.35% | 2.7M +12.12% | |
Total Assets | 9.3M -11.32% | 10.4M -8.47% | 11.4M +30.43% | 8.7M -8.71% | |
Income Taxes Payable | N/A N/A | 0 -100.00% | 12,255 -60.30% | 30,866 -68.37% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 520,957 -73.30% | 2.0M +19.64% | 1.6M -18.62% | 2.0M -13.94% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 116,899 -26.82% | 159,741 +43.89% | 111,018 +56.20% | 71,072 +7.92% | |
Total Liabilities | 637,856 -69.78% | 2.1M +21.19% | 1.7M -16.06% | 2.1M -13.34% | |
Retained Earnings | -6.4M +86.70% | -3.4M +86.66% | -1.8M -259.49% | 1.2M -23.54% | |
Total Stockholders Equity | 8.6M +3.51% | 8.3M -13.82% | 9.7M +44.90% | 6.7M -7.17% | |
Total Shares Outstanding | 2.4M -86.55% | 18.0M +1.70% | 17.7M -89.83% | 173.7M +1.46% | |
Cash Flow | |||||
Cash from Operating Activities | -1.8M -17.72% | -2.2M +71.66% | -1.3M -339.25% | 544,028 +5,838.52% | |
Capital Expenditures | 36,971 -83.71% | 226,989 +1,260,950.00% | 18 -99.97% | 54,171 +1,613.19% | |
Cash from Investing Activities | 944,751 +125.91% | 418,202 +209.31% | -382,576 -15.08% | -450,498 -8.17% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 298,841 +106.13% | 144,975 -97.48% | 5.8M +4,862.25% | 115,962 +510.89% | |
Financials Ratio | |||||
Gross Margin | 14.62% +7.80% | 13.56% -0.35% | 13.61% +18.11% | 11.52% -29.83% | |
Operating Margin | -39.93% +141.34% | -16.55% -37.66% | -26.54% +896.30% | -2.66% -133.72% | |
Return on Assets | -30.32% +107.10% | -14.64% -43.92% | -26.11% +571.63% | -3.89% -150.92% | |
Return on Equity | -35.24% +98.23% | -17.78% -44.81% | -32.21% +526.44% | -5.14% -147.35% | |
Revenue Growth | -21.93% +723.65% | -2.66% -74.87% | -10.59% -41.83% | -18.21% -205.20% | |
Current Ratio | 10.46 +174.67% | 3.81 -22.82% | 4.93 +64.20% | 3.00 -2.13% | |
Cash Ratio | 4.58 +463.77% | 0.81 -49.56% | 1.61 +426.99% | 0.31 +22.91% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow